Apretude

Apretude (cabotegravir) is a prescription medication used to treat HIV prevention (PrEP). A long-acting injectable for HIV pre-exposure prophylaxis (PrEP), given every two months to reduce the risk of getting HIV.

An integrase inhibitor that blocks HIV from establishing infection in people who are exposed to the virus.

Commonly reported side effects of Apretude include Injection site reactions, Headache, Fever, Fatigue, and Must confirm HIV-negative before each dose. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Apretude has notable warnings and precautions. Tell your doctor about your medical history and any other medicines or supplements you take before starting Apretude.

The active ingredient in Apretude is cabotegravir, which belongs to a class of medicines known as Integrase Inhibitor (Long-Acting Injectable PrEP).

Apretude is manufactured by ViiV Healthcare. It was first approved in 2021.

You may be able to lower the cost of Apretude by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.